ConductScience.org, home

Paper3753554

Comparative pharmacokinetics and metabolism of doxorubicin and 4-demethoxy-4'-O-methyldoxorubicin in tumor-bearing mice.

Formelli F and 2 others. Cancer Chemother Pharmacol, 1986. Cited by 19 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Comparative pharmacokinetics and metabolism of doxorubicin and 4-demethoxy-4'-O-methyldoxorubicin in tumor-bearing mice. Papers, record 3753554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3753554

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative pharmacokinetics and metabolism of doxorubicin and 4-demethoxy-4'-O-methyldoxorubicin in tumor-bearing mice.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1986
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
1.07
iCite
Revised in PubMed
2019-08-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Formelli FF
2Carsana RR
3Pollini CC

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DoxorubicinMajor topic
Animals
Carcinoma
Colonic Neoplasms
Female
Liver
Metabolic Clearance Rate
Mice
Tissue Distribution

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17296751Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7296751PubMed
26244090Clinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis.Cancer Res1980https://conductscience.org/library/papers/6244090PubMed
3294954Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/294954PubMed
46459335Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasma.J Chromatogr1981https://conductscience.org/library/papers/6459335PubMed
54417723Adriamycin and daunorubicin disposition in the rabbit.J Pharmacol Exp Ther1974https://conductscience.org/library/papers/4417723PubMed
64715566A fluorometric assay for daunomycin and adriamycin in animal tissues.Biochem Med1973https://conductscience.org/library/papers/4715566PubMed
7647696Synthesis and antitumor activity of 4-demethoxyadriamycin and 4-demethoxy-4' -epiadriamycin.Cancer Treat Rep1978https://conductscience.org/library/papers/647696PubMed
86930988Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia.Cancer Lett1980https://conductscience.org/library/papers/6930988PubMed
9884924Bilary disposition of adriamycin.Clin Pharmacol Ther1977https://conductscience.org/library/papers/884924PubMed
10119583Comparative metabolism and excretion of adriamycin in man, monkey, and rat.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/119583PubMed
116575865Synthesis, antitumor activity, and cardiac toxicity of new 4-demethoxyanthracyclines.Cancer Treat Rep1983https://conductscience.org/library/papers/6575865PubMed
127090422Body residue and metabolism of adriamycin and daunorubicin in control and phenobarbital-pretreated mice.Xenobiotica1982https://conductscience.org/library/papers/7090422PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
29987398A Multiscale Physiologically-Based Pharmacokinetic Model for Doxorubicin to Explore its Mechanisms of Cytotoxicity and Cardiotoxicity in Human Physiological Contexts.Pharm Res2018https://conductscience.org/library/papers/29987398PubMed
8004751Quantitation of cell-associated doxorubicin by high-performance liquid chromatography after enzymatic desequestration.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8004751PubMed
3741758In vivo characterization of a doxorubicin resistant B16 melanoma cell line.Br J Cancer1986https://conductscience.org/library/papers/3741758PubMed
3370742Effect of verapamil on doxorubicin activity and pharmacokinetics in mice bearing resistant and sensitive solid tumors.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3370742PubMed
3358904Doxorubicin cellular pharmacokinetics and DNA breakage in a multi-drug resistant B16 melanoma cell line.Br J Cancer1988https://conductscience.org/library/papers/3358904PubMed
2691361Streptomycetes producing daunomycin and related compounds: do we know enough about them after 25 years?Folia Microbiol (Praha)1989https://conductscience.org/library/papers/2691361PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3753554

GET https://conductscience.org/api/papers/v1/3753554/authors